Symphony has reported significant product development and regulatory approval. Most notably it has received enhanced US Food & Drug Administration (FDA) and Health Canada approval for introduction of d2p anti-microbial technology for bread packaging in these markets. Our analysis shows the total market in North America for bread products is valued at c.$24bn each year. In the recent H1 statement, the Group reported revenue growth of 13% to £5.4m (at constant FX) but a loss before tax of £0.6m (i ....
24 Sep 2021
Symphony Environmental (SYM LN) - Building blocks in place
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Symphony Environmental (SYM LN) - Building blocks in place
Symphony Environmental Technologies plc (SYM:LON) | 3.2 0 0.0% | Mkt Cap: 6.01m
- Published:
24 Sep 2021 -
Author:
Robin Byde -
Pages:
14
Symphony has reported significant product development and regulatory approval. Most notably it has received enhanced US Food & Drug Administration (FDA) and Health Canada approval for introduction of d2p anti-microbial technology for bread packaging in these markets. Our analysis shows the total market in North America for bread products is valued at c.$24bn each year. In the recent H1 statement, the Group reported revenue growth of 13% to £5.4m (at constant FX) but a loss before tax of £0.6m (i ....